导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -8.50% | 3657/4773 |
| 近一周 | -2.12% | 1265/5462 |
| 近一月 | -1.07% | 857/5421 |
| 近一季 | -3.29% | 1386/5209 |
| 近半年 | -6.66% | 3120/4920 |
| 近一年 | -5.85% | 3166/4366 |
| 近两年 | 33.41% | 2147/2954 |
| 近三年 | 27.72% | 1150/2253 |
| 成立以来 | 60.13% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-8.26% 4272/4961 |
1.92% 2978/5312 |
- - |
- - |
| 2025 | 15.57% 2533/4813 |
5.09% 833/3635 |
-4.77% 3503/4076 |
14.57% 2893/4524 |
0.80% 1762/4813 |
| 2024 | 25.17% 269/3463 |
6.53% 287/2808 |
-0.67% 816/3014 |
16.88% 1323/3129 |
1.20% 1104/3463 |
| 2023 | 5.05% 202/2656 |
9.39% 407/2280 |
5.08% 74/2385 |
-4.39% 1133/2515 |
-4.40% 1011/2655 |
| 2022 | -20.09% 930/2207 |
-20.73% 1568/1919 |
14.84% 189/2016 |
-10.94% 473/2113 |
-1.44% 1702/2208 |
| 2021 | -7.02% 1025/1822 |
-0.32% 351/1255 |
2.50% 1002/1330 |
-14.92% 1376/1466 |
6.96% 196/1822 |
| 2020 | 35.17% 422/1250 |
-11.31% 833/1028 |
15.90% 467/1067 |
12.96% 350/1164 |
16.41% 173/1184 |
| 2019 | 43.95% 182/1092 |
31.78% 189/739 |
-0.29% 239/788 |
-3.07% 725/850 |
13.02% 31/918 |
| 2018 | -30.97% 484/834 |
- - |
-3.78% 81/631 |
-16.10% 657/660 |
-11.50% 304/682 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 景顺长城中证港股通创新药ETF | 1.6507 | 28.23% |
| 港股医疗 | 0.9366 | 28.18% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 港股通医疗ETF工银 | 0.9464 | 28.06% |
| 港股通医疗ETF华宝 | 0.9577 | 27.97% |
| 天弘恒生沪深港创新药精选50ETF发起联接C | 1.2844 | 27.92% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 万家中证港股通创新药ETF发起式联接A | 1.3863 | 27.32% |
| 万家中证港股通创新药ETF发起式联接C | 1.3856 | 27.27% |
| 广发中证全指家用电器ETF联接C VS. 长安沪深300非周期A(740101) |